A PSA blood test can help find prostate cancer, but experts often disagree on who needs one and what the results actually ...

A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men ...

Per 1,000 men screened, the Stockholm3 test detected 31.6 clinically significant prostate cancer cases compared with 25.8 for ...

Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease. The move, announced by ...

In the current issue of Prostate Cancer Prostatic Diseases, Szymaniak and colleagues from UCSF present long term oncologic outcomes of patients who presented a non-detectable PSA after radical ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...